Filing Flows › Orthopediatrics (KIDS) › Q2 2026
Orthopediatrics (KIDS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
Orthopediatrics (KIDS) reported revenue of $70.5M for the second quarter 2026 (Q2 2026), +15% from a year earlier and +19% from the quarter before. Operating margin was -5.8%, net loss $7.2M (10.2% of revenue).
Orthopediatrics, Q2 2026: revenue $70.5M (+15% year over year), operating margin -5.8%, net loss $7.2M, operating cash flow $928K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.5M | +19% | +15% |
| Operating profit | −$4.1M | — | — |
| Net earnings | −$7.2M | — | — |
| Operating cash flow | $928K | — | — |
What changed
Revenue was $70.5M in Q2 2026, up 15% year over year and up 19% from the previous quarter. Trauma and deformity was the largest line at 75% of revenue. Trauma and deformity added $11.0M year over year (up 26%), 116% of the total change. Scoliosis declined 9%.
Gross margin was 74.3%, up 2.2 points from Q2 2025. Operating costs exceeded revenue by $4.1M, an operating margin of -5.8%. Operating expenses grew 3% against revenue growth of 15%. The fastest-growing cost line was Sales & marketing (+11%). The quarter ended with a net loss of $7.2M, narrower than the previous quarter's $10.7M loss.
Operating cash flow was $928K. Non-cash charges added back $5.7M of depreciation and amortization and $4.2M of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of $4.0M exceeded it, leaving free cash flow of −$3.1M.
Questions
What was Orthopediatrics' revenue in the second quarter 2026?
Orthopediatrics (KIDS) reported revenue of $70.5M for the second quarter 2026 (Q2 2026), +15% from a year earlier and +19% from the quarter before.
Was Orthopediatrics profitable in the second quarter 2026?
Operating loss was $4.1M (-5.8% of revenue) and net loss $7.2M.
Source: Orthopediatrics 10-Q on SEC EDGAR.